134 related articles for article (PubMed ID: 12204970)
1. Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents.
Leach CT; Ashley RL; Baillargeon J; Jenson HB
Clin Diagn Lab Immunol; 2002 Sep; 9(5):1124-5. PubMed ID: 12204970
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays.
Liermann K; Schäfler A; Henke A; Sauerbrei A
J Virol Methods; 2014 Apr; 199():29-34. PubMed ID: 24418499
[TBL] [Abstract][Full Text] [Related]
3. Secreted portion of glycoprotein g of herpes simplex virus type 2 is a novel antigen for type-discriminating serology.
Görander S; Svennerholm B; Liljeqvist JA
J Clin Microbiol; 2003 Aug; 41(8):3681-6. PubMed ID: 12904375
[TBL] [Abstract][Full Text] [Related]
4. Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus.
Martins TB; Woolstenhulme RD; Jaskowski TD; Hill HR; Litwin CM
Am J Clin Pathol; 2001 Feb; 115(2):272-7. PubMed ID: 11211617
[TBL] [Abstract][Full Text] [Related]
5. Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.
Ngo TD; Laeyendecker O; La H; Hogrefe W; Morrow RA; Quinn TC
Clin Vaccine Immunol; 2008 Feb; 15(2):382-4. PubMed ID: 18077617
[TBL] [Abstract][Full Text] [Related]
6. Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.
Liu T; Liu JF; Yu H; Si GJ; Hu J; Li J
Singapore Med J; 2015 Jun; 56(6):346-52. PubMed ID: 25532518
[TBL] [Abstract][Full Text] [Related]
7. Sorting out the new HSV type specific antibody tests.
Ashley RL
Sex Transm Infect; 2001 Aug; 77(4):232-7. PubMed ID: 11463920
[TBL] [Abstract][Full Text] [Related]
8. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
Ashley-Morrow R; Nollkamper J; Robinson NJ; Bishop N; Smith J
Clin Microbiol Infect; 2004 Jun; 10(6):530-6. PubMed ID: 15191381
[TBL] [Abstract][Full Text] [Related]
9. Novel recombinant ELISA assays for determination of type-specific IgG antibodies against HSV-1 and HSV-2.
Sauerbrei A; Wutzler P
J Virol Methods; 2007 Sep; 144(1-2):138-42. PubMed ID: 17548119
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of four type-specific commercial assays for detection of herpes simplex virus type 1 antibodies in a Middle East and North Africa population.
Aldisi RS; Elsidiq MS; Dargham SR; Sahara AS; Al-Absi ES; Nofal MY; Mohammed LI; Abu-Raddad LJ; Nasrallah GK
J Clin Virol; 2018 Jun; 103():1-7. PubMed ID: 29597097
[TBL] [Abstract][Full Text] [Related]
11. Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2.
Morrow RA; Friedrich D
Am J Clin Pathol; 2003 Dec; 120(6):839-44. PubMed ID: 14671972
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immunoassays for differentiation of herpes simplex virus type 1 and 2 antibodies.
Qutub MO; Klapper PE; Vallely PJ; Cleator GM; Mandall D
Saudi Med J; 2006 Jun; 27(6):788-93. PubMed ID: 16758036
[TBL] [Abstract][Full Text] [Related]
13. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
Wald A; Ashley-Morrow R
Clin Infect Dis; 2002 Oct; 35(Suppl 2):S173-82. PubMed ID: 12353203
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel serology algorithm to detect herpes simplex virus 1 or 2 antibodies.
Zahariadis G; Severini A
Sex Transm Dis; 2010 Nov; 37(11):696-9. PubMed ID: 20693937
[TBL] [Abstract][Full Text] [Related]
15. False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands.
van Rooijen MS; Roest W; Hansen G; Kwa D; de Vries HJ
Sex Transm Infect; 2016 Jun; 92(4):257-60. PubMed ID: 26755775
[TBL] [Abstract][Full Text] [Related]
16. Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.
Al-Sulaiman AM; Vallely PJ; Klapper PE
Clin Vaccine Immunol; 2009 Jun; 16(6):931-4. PubMed ID: 19369475
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of herpes simplex virus types 1 and 2 among children and adolescents attending a sexual abuse clinic.
Ramos S; Lukefahr JL; Morrow RA; Stanberry LR; Rosenthal SL
Pediatr Infect Dis J; 2006 Oct; 25(10):902-5. PubMed ID: 17006285
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2.
Binnicker MJ; Jespersen DJ; Harring JA
Clin Vaccine Immunol; 2010 Feb; 17(2):253-7. PubMed ID: 20007366
[TBL] [Abstract][Full Text] [Related]
19. [ELISA study on application of recombinant glycoprotein D of herpes simplex virus-1 in diagnosis of herpes simplex virus-1 infection with ELISA].
Wang ZY; Wang ZY; Wen HL; Tao ZX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):159-61. PubMed ID: 16027786
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a fully automated glycoprotein G-2 based assay for the detection of HSV-2 specific IgG antibodies in serum and plasma.
Groen J; Hersmus B; Niesters HG; Roest W; van Dijk G; van der Meijden W; Osterhaus AD
J Clin Virol; 1999 May; 12(3):193-200. PubMed ID: 10382816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
